Cardiac tissue ablation with catheter-based microwave heating.
Rappaport C.
Int J Hyperthermia. 2004 Nov;20(7):769-80. doi: 10.1080/02656730412331286885.
Acquired Pulmonary Vein Stenosis After Radiofrequency Ablation for Atrial Fibrillation: Single-Center Experience in Catheter Interventional Treatment.
Schoene K, Arya A, Jahnke C, Paetsch I, Nedios S, Hilbert S, Bollmann A, Hindricks G, Sommer P.
JACC Cardiovasc Interv. 2018 Aug 27;11(16):1626-1632. doi: 10.1016/j.jcin.2018.05.016.
Percutaneous transluminal septal myocardial ablation: past, present, and future.
Maekawa Y, Takamisawa I, Takano H, Takayama M.
J Cardiol. 2022 Sep;80(3):211-217. doi: 10.1016/j.jjcc.2021.11.023. Epub 2021 Dec 16.
Interventions in Kawasaki disease.
Akagi T.
Pediatr Cardiol. 2005 Mar-Apr;26(2):206-12. doi: 10.1007/s00246-004-0964-2.
Percutaneous transluminal septal myocardial ablation: a new catheter-based therapy for patients with hypertrophic obstructive cardiomyopathy.
Farouque HM, Worthley SG, Skyrme-Jones RA, Hope SA, Meredith IT.
Heart Lung Circ. 2001;10(2):63-7. doi: 10.1046/j.1444-2892.2001.00085.x.
Contemporary Septal Reduction Therapy in Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.
Maekawa Y, Akita K, Takanashi S.
Circ J. 2018 Jul 25;82(8):1977-1984. doi: 10.1253/circj.CJ-18-0575. Epub 2018 Jun 15.
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Seggewiss H, Faber L, Ziemssen P.
Cardiol Rev. 1999 Nov-Dec;7(6):316-23. doi: 10.1097/00045415-199911000-00009.
MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Amano Y, Takayama M, Amano M, Kumazaki T.
AJR Am J Roentgenol. 2004 Feb;182(2):523-7. doi: 10.2214/ajr.182.2.1820523.
Improved blood flow after percutaneous transluminal septal myocardial ablation visualized by 4D flow cardiac magnetic resonance in a case of hypertrophic obstructive cardiomyopathy.
Suwa K, Akita K, Iguchi K, Sugiyama M, Maekawa Y.
Eur Heart J Cardiovasc Imaging. 2018 Dec 1;19(12):1389. doi: 10.1093/ehjci/jey130.
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension.
Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Böhm M, Campese VM, Francis DP, Grassi G, Hering D, Katholi R, Kjeldsen S, Krum H, Mahfoud F, Mancia G, Messerli FH, Narkiewicz K, Parati G, Rocha-Singh KJ, Ruilope LM, Rump LC, Sica DA, Sobotka PA, Tsioufis C, Vonend O, Weber MA, Williams B, Zeller T, Esler MD.
J Am Coll Cardiol. 2013 Dec 3;62(22):2031-45. doi: 10.1016/j.jacc.2013.08.1616. Epub 2013 Sep 18.
